Skip to main content

Table 1 Sample Characteristics (n = 743)

From: Validation of adult asthma case definitions for primary care sentinel surveillance

Characteristic

n

Mean (SD)

Median (Range)

Age, years

743

50.3 (8.7)

48.7 (18–93)

 

Subcategory

n (%)

Sex

Male

327 (44)

Female

416 (56)

Smoking History

Never

345 (46)

Past

206 (28)

Current

192 (26)

Comorbidity

Allergic rhinitis

76 (10)

ACOS

10 (1)

Bronchiectasis

8 (1)

Chronic bronchitis

17 (2)

Congestive heart failure

25 (3)

COPD

47 (6)

Cor pulmonale

0 (0)

Emphysema

11 (2)

GERD

235 (32)

Sleep apnea

87 (12)

Medication

Expired

n (%)

Current

n (%)

Total

(Expired + Current)

n (%)

 SABA

98 (13)

96 (13)

194 (26)

 SAMA

3 (0)

3 (0)

6 (1)

 SAMA/SABA

0 (0)

0 (0)

0 (0)

 ICS

77 (10)

45 (6)

122 (16)

 LABA

3 (0)

5 (1)

8 (1)

 LAMA

4 (1)

9 (1)

13 (2)

 ICS/LABA

10 (1)

27 (4)

37 (5)

 LAMA/LABA

0 (0)

3 (0)

3 (0)

 ICS/LABA/LAMA

0 (0)

1 (0)

1 (0)

 LTRA

1 (0)

0 (0)

1 (0)

 Biologics

1 (0)

8 (1)

9 (1)

 Systemic steroids

50 (7)

39 (5)

89 (12)

 Other

50 (7)

673 (91)

723 (97)

Location

n (%)

 Asthma in cumulative patient profile

73 (10)

 Asthma in disease registry

38 (5)

 Asthma referral notes

39 (5)

 Asthma in free text

252 (34)

 Asthma elsewhere in patient chart

34 (5)

Other asthma documentation data

n (%)

 Asthma synonyms in patient chart

88 (12)

 Work-related asthma in patient chart

12 (2)

 Family history of asthma in patient chart

25 (3)

 Childhood diagnosis of asthma in patient chart

49 (7)

Use of objective measures of lung function

n (%)

 Spirometry performed

114 (15)

 Bronchodilator challenge test performed

86 (11)

 Methacholine challenge test performed

15 (2)

 Exercise challenge test performed

4 (1)

Method of confirmation of asthma diagnosis

n (%)

 Specialist diagnosis

3 (0)

 Spirometry

13 (1)

 Methacholine challenge test

3 (0)

 Exercise challenge test

0 (0)

  1. ACOS Asthma-COPD Overlap Syndrome, COPD Chronic Obstructive Pulmonary Disease, GERD Gastroesophageal Reflux Disease
  2. ICS Inhaled corticosteroid, LABA Long-acting β-agonist, LAMA Long-acting muscarinic antagonist, LTRA Leukotriene receptor antagonist, SABA Short-acting β-agonist, SAMA Short-acting muscarinic antagonist